Insurance coverage, pricing, and eligibility criteria change frequently
For a 50-year-old female with obesity, type 2 diabetes, and hypertension who is currently taking tirzepatide (Mounjaro) 12.5 mg weekly, phentermine 37.5 mg daily, losartan 50 mg, and spironolactone 50 mg, is it appropriate and safe to increase tirzepatide to 15 mg, continue phentermine for another month, and maintain her current antihypertensive regimen?
Choosing poor forms: Liposomal glutathione and sublingual glutathione may offer better stability than standard capsules
Even small doses maintain hormonal balance and help stabilize glucose metabolism
Constipation: A Less Expected but Important Side Effect While diarrhea receives more attention, constipation affects 15 to 25 percent of semaglutide patients, particularly after the first 4 to 6 weeks when the initial diarrhea phase resolves
CAS: 2381089-83-2